Molecular identification of trypanosoma cruzi discrete typing units in end-stage chronic chagas heart disease and reactivation after heart transplantation

Clinical Infectious Diseases

Volumn 51, Issue 5, 2010, Pages 485-495

  Burgos, Juan Miguel ^a   Diez, Mirta ^b   Vigliano, Carlos ^b   Bisio, Margarita ^a   Risso, Marikena ^c   Duffy, Tomás ^a   Cura, Carolina ^a   Brusses, Betina ^d   Favaloro, Liliana ^b   Leguizamon, María Susana ^c   Lucero, Raul Horacio ^d   Laguens, Ruben ^b   Levin, Mariano Jorge ^a   Favaloro, Roberto ^b   Schijman, Alejandro Gabriel ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

MINICIRCLE DNA;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYOCARDITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PRIORITY JOURNAL; RECURRENT DISEASE; SOUTH AMERICA; TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FEMALE; GENOTYPE; HEART; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIUM; RECURRENCE; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 77955811175     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655680     Document Type: Article

References (41)

1. World Health Organization (WHO). Control of Chagas disease: report of a WHO expert committee. WHO Tech Rep Ser 2002; 905:1-109.
2. Rassi A Jr, Rassi A, Marin-Neto J.A. Chagas disease. Lancet 2010; 375: 1388-1402.
3. Feldman AM, Mac Namara D. Myocarditis. N Engl J Med 2000; 343: 1388-1398.
4. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment followup in heart transplantation. Am J Transplant 2007; 7:1633-1640.
5. Bestetti RB, Theodoropoulos T.A. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail 2009; 15:249-255.
6. Chagas C. Nova entidade morbida do homem: resumo geral de estudos etioló gicos e clínicos. Mem Inst Oswaldo Cruz 1911; 3:219-275.
7. Tibayrenc M, Ward P, Moya A, Ayala F. Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci U S A 1986; 83:115-119.
8. Machado C, Ayala F. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc Natl Acad Sci U S A 2001; 98:7396-7401.
9. Brisse S, Barnabé C, Tibayrenc M. Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. Int J Parasitol 2000; 30:35-44.
10. Zingales B, Andrade SG, Briones MR, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revisionmeeting recommends TcI to Tc.V.I. Mem Inst Oswaldo Cruz 2009; 104:1051-1054.
11. Macedo AM, Machado CR, Oliveira R, Pena SD.J. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 2004; 99: 1-12.
12. Campbell DA,Westenberger SJ, Sturm N.R. The determinants of Chagas disease: connecting parasite and host genetics. Curr Mol Med 2004; 4:549-562.
13. Miles MA, Llewellyn MS, Lewis MD, et al. The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future. Parasitology 2009; 136: 1509-1528.
14. Di Noia JM, Buscaglia CA, De Marchi CR, Almeida IC, Frasch A.C. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J Exp Med 2002; 195:401-413.
15. Carranza JC, Valadares HM, D'Ávila DA, et al. Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil. Int J Parasitol 2009; 39:963-973.
16. Cardinal MV, Lauricella MA, Ceballos LA, et al. Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina. Int J Parasitol 2008; 38:1533-1543.
17. Burgos JM, Altcheh J, Bisio M, et al. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing Congenital Chagas disease. Int J Parasitol 2007; 37:1319-1327.
18. Diosque P, Barnabe C, Padilla AM, et al. Multilocus enzyme electrophoresis analysis of Trypanosoma cruzi isolates from a geographically restricted endemic area for Chagas' disease in Argentina. Int J Parasitol 2003; 33:997-1003.
19. Freitas JM, Lages-Silva E, Crema E, Pena SD, Macedo A.M. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol 2005; 35:411-417.
20. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1:3-14.
21. Kunkel B, Kober G, Lapp H, Leuschner U, Kaltenbach M. Clinical light and electron microscopic findings in patients with late and early congestive cardiomyopathies. Z Kardiol 1977; 66:198-202.
22. Stewart S,Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720.
23. Strout R.G. A method for concentrating hemoflagellates. J Parasitol 1962; 48:100.
24. Schijman AG, Vigliano CA, Viotti RJ, et al. Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease. Am J Trop Med Hyg 2004; 70:210-220.
25. Brisse S, Dujardin JC, Tibayrenc M. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol 2000; 111:95-105.
26. Falla A, Herrera C, Fajardo A, Montilla M, Vallejo GA, Guhl F. Genotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans. Acta Trop 2009; 110: 15-21.
27. Burgos JM, Begher S, Silva HM, et al. Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AID.S. Am J Trop Med Hyg 2008; 78:294-297.
28. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 2001; 31:550-554.
29. Higuchi M de L, Gutierrez PS, Aiello VD, et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993; 423:157-160.
30. Benvenuti LA, Roggério A, Freitas HF, et al. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008; 102:481-487.
31. Jacob S, Sellke F. Is bicaval orthotopic heart transplantation superior to the biatrial technique? Interact Cardiovasc Thorac Surg 2009; 9: 333-342.
32. Palomino SA, Aiello VD, Higuchi M.L. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 2000; 94:571-579.
33. Bertolino ND, Villafanha DF, Cardinalli-Neto A, et al. Prognostic impact of Chagas' disease in patients awaiting heart transplantation. J Heart Lung Transplant 2010; 29:449-453.
34. Duffy T, Bisio M, Altcheh J, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl Trop Dis 2009; 3:e419.
35. Bocchi EA, Fiorelli A. The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant 2001; 20:637-645.
36. Almeida DR, Carvalho AC, Branco JN, et al. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment. J Heart Lung Transplant 1996; 15:988-992.
37. Pinazo MJ, Espinosa G, Gállego M, López-Chejade PL, Urbina JA, Gascón J. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg 2010; 82:583-587.
38. Valadares HM, Pimenta JR, de Freitas JM, et al. Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites. Int J Parasitol 2008; 38:839-850.
39. Sturm NR, Campbell D.A. Alternative lifestyles: the population structure of Trypanosoma cruzi. Acta Trop 2010; 115:35-43.
40. Tomazi L, Kawashita SY, Pereira PM, Zingales B, BrionesM.R. Genotype distribution of five nuclear genes based on network genealogies and Bayesian inference indicates that Trypanosoma cruzi hybrid strains are polyphyletic. Genet Mol Res 2009; 8:458-476.
41. Gaunt MW, Yeo M, Frame IA, et al. Mechanism of genetic exchange in American trypanosomes. Nature 2003; 421:936-939.